Mazor Robotics Ltd. (NASDAQ:MZOR) is scheduled to post its quarterly earnings results before the market opens on Tuesday, August 1st. Analysts expect Mazor Robotics to post earnings of ($0.25) per share for the quarter.

Mazor Robotics (NASDAQ:MZOR) last released its quarterly earnings results on Wednesday, May 10th. The medical instruments supplier reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by $0.02. The firm had revenue of $11.70 million during the quarter, compared to analyst estimates of $11.49 million. Mazor Robotics had a negative return on equity of 30.90% and a negative net margin of 45.08%. The business’s revenue was up 82.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.10) EPS. On average, analysts expect Mazor Robotics to post $-0.89 EPS for the current fiscal year and $-0.55 EPS for the next fiscal year.

Mazor Robotics Ltd. (MZOR) traded down 4.20% during midday trading on Thursday, hitting $38.99. The company had a trading volume of 148,493 shares. Mazor Robotics Ltd. has a 12-month low of $19.75 and a 12-month high of $45.64. The stock’s market cap is $930.89 million. The company’s 50 day moving average is $36.81 and its 200 day moving average is $31.16.

Several brokerages recently commented on MZOR. JMP Securities cut Mazor Robotics from an “outperform” rating to a “market perform” rating in a report on Friday, May 12th. They noted that the move was a valuation call. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a report on Thursday, July 6th. Ladenburg Thalmann Financial Services reaffirmed a “buy” rating and issued a $46.00 price target on shares of Mazor Robotics in a report on Monday, June 12th. Zacks Investment Research cut Mazor Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Finally, Standpoint Research cut Mazor Robotics from a “buy” rating to a “reduce” rating and dropped their price target for the company from $32.98 to $28.00 in a report on Wednesday, April 19th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company’s stock. Mazor Robotics has a consensus rating of “Hold” and an average price target of $33.50.

TRADEMARK VIOLATION WARNING: “Mazor Robotics Ltd. (NASDAQ:MZOR) to Release Earnings on Tuesday” was posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at

Mazor Robotics Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Earnings History for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with's FREE daily email newsletter.